In Genome Medicine, diet-triggered delivery beat constant secretion on fat and liver fat, and kept down gut microbes carrying GLP-1-degrading peptidase genes.
Recap by typeshit. Full story at Bioengineer.org.
He says close to 40% of weight lost in the trial's body-scan group was lean mass, and argues muscle loss isn't the drug's fault.
Wayne Pratt walks through what happens in the brain when drugs like Ozempic dial down the constant background chatter about eating.
Bikman cites a trial where people who lost about 21% and switched to placebo regained 14% within a year, while those who stayed on kept losing.
Medical Xpress reports the weekly experimental drug beat placebo, which cut about 10 pauses per hour, in people with sleep apnea.
29:58
Meg takes her weekly tirzepatide shot on camera and steps on the scale to share where her weight loss stands so far.
Strive Specialties failed to revive its suit over GLP-1 competition. Novo still faces soft 2026 forecasts and an exploratory CagriSema analysis in women.
Loading…